Hasil Pencarian - L Nieuwenhuizen

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Impact of organizational context on patient outcomes in a proactive primary care program:a longitudinal observational study

    Impact of organizational context on patient outcomes in a proactive primary care program:a longitudinal observational study oleh Linda C. Smit, Niek J. De Wit, Meggie L. Nieuwenhuizen, Marieke J. Schuurmans, Nienke Bleijenberg

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

    Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study) oleh Tine M.H.J. Goedhart, Laura H. Bukkems, Michiel Coppens, Karin J. Fijnvandraat, Saskia E.M. Schols, Roger E.G. Schutgens, Jeroen Eikenboom, Floor C.J.I. Heubel-Moenen, Paula F. Ypma, L. Nieuwenhuizen, K. Meijer, Frank W. G. Leebeek, Ron A.A. Mathôt, Marjon H. Cnossen

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders

    Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders oleh F. Atiq, J.L. Saes, M.C. Punt, K.P.M. van Galen, R.E.G. Schutgens, K. Meijer, M.H. Cnossen, B.A.P. Laros-Van Gorkom, M. Peters, L. Nieuwenhuizen, M.J.H.A. Kruip, J. de Meris, J.G. van der Bom, F.J.M. van der Meer, K. Fijnvandraat, I.C. Kruis, W.L. van Heerde, H.C.J. Eikenboom, Frank W.G. Leebeek, S.E.M. Schols

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study

    Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable... oleh Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: